Healthcare professionals presenting at medical conference

Scientific Congresses in Allergy and Immunology

Scientific Congresses and Resources

This is not intended to be a comprehensive resource of all congresses and congress materials across therapeutic and disease areas. Congress materials may include information about investigational use(s) of compounds/products that are not approved for use by the U.S. Food and Drug Administration (FDA) and/or are inconsistent with the Prescribing Information. Takeda does not recommend the use of any Takeda product beyond the approved labeling. Any decisions regarding the usage of a Takeda product beyond the approved labeling are left to the discretion of the healthcare professional. Takeda makes no representations about whether investigational compounds or unapproved uses will be approved by the FDA.

American College of Allergy, Asthma & Immunology (ACAAI), 2025

November 6 - 10, 2025 | Link to Event

Global meeting featuring thought leaders from around the world focused on advancing patient care in allergy and immunology.

Annual Meeting American Academy of Allergy Asthma and Immunology (AAAAI), 2026

February 27 - March 2, 2026 | Link to Event

Premier global educational event for allergists and immunologists, with thousands of attendees each year, discussing allergies, asthma, and immune deficiency disorders.

American Academy of Neurology (AAN), 2026

April 18 - 22, 2026 | Link to Event

Each year, the American Academy of Neurology's Annual Meeting offers a robust lineup of diverse learning opportunities covering nearly every topic and subspecialty, helping you stay up to date on the latest trusted science and essential education.

National Home Infusion Association (NHIA), 2026

April 18 - 22, 2026 | Link to Event

Brings together home and alternate site infusion professionals for four days of networking, education, and exhibits. The expo features companies displaying the latest products and services supporting the industry.

American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM), 2025

October 29 - November 1, 2025

Annual meeting dedicated to the advancement of neuromuscular, musculoskeletal, and electrodiagnostic medicine.

Immunoglobulin National Society (IgNS), 2025

October 16 - 19, 2025

National conference of IgNS bringing together professionals and practitioners from all disciplines and clinical specialties to advance Ig therapy practice, while providing networking and comprehensive education opportunities.

Hereditary Angioedema National Summit (HAEA), 2025

July 10 - 13, 2025

This event brings together over 1200 HAE community members, including families, caregivers, healthcare professionals, and pharmaceutical representatives.

Takhzyro® (lanadelumab-flyo)

  • Longitudinal Trend in Attack Outcomes in Patients With Hereditary Angioedema Receiving Long-term Prophylaxis with Lanadelumab: An Observational Study
  • Physician-Reported Attack Rates and Attack Characteristics Among Patients With Hereditary Angioedema Who Extended Dosing With Lanadelumab: An EMPOWER Study Analysis
  • Treatment Outcomes With Lanadelumab by Baseline Hereditary Angioedema Activity: EMPOWER/ENABLE Analysis

Eastern Allergy Conference (EAC), 2025

May 29 - June 1, 2025

Regional annual conference discussing the most current information from top experts in allergy, asthma, and immunology.

Takhzyro® (lanadelumab-flyo)

  • Lanadelumab’s Sustained Effectiveness and Safety for Hereditary Angioedema Long-Term Prophylaxis in Patients From Puerto Rico: Final Results From the EMPOWER Study
  • Understanding the Impact of Long-Term Prophylaxis Switches for Patients With Hereditary Angioedema.

American Thoracic Society (ATS), 2025

May 16 - 21, 2025

International conference showcasing the latest advances in pulmonary disease, critical illness, and sleep disorders for scientists and clinicians at all stages of their careers.

Glassia® [Alpha1- Proteinase Inhibitor (Human)]

  • Application of an Artificial Intelligence Model to Detect Alpha-1 Antitrypsin Deficiency: Characterizing the Study Population
  • Application of an Artificial Intelligence Model to Detect Alpha-1 Antitrypsin Deficiency: Model Performance

Clinical Immunology Society (CIS), 2025

May 1 - 4, 2025

Annual meeting with the goal of providing a stimulating forum with presentations and discussions on the latest advances in clinical immunology, including primary immunodeficiencies and immune dysregulatory diseases.

American Academy of Neurology (AAN), 2025

April 5 - 9, 2025

Annual meeting in neurology promoting high quality patient-centric care in a variety of topics and specialties through various learning formats.

  • Real-World Characteristics and Disease Management for a Virtual Longitudinal Cohort of Patients with Chronic Inflammatory Demyelinating Polyneuropathy

Academy of Managed Care Pharmacy (AMCP), 2025

March 31 - April 3, 2025

Large assembly of pharmacy and healthcare professionals dedicated to the issues of managed care pharmacy, offering immersive education sessions and keynote presentations.

  • Epidemiology, Patient Characteristics, Real-World Treatment Patterns, and Outcomes for Patient with Multifocal Motor Neuropathy (MMN)
  • Disease Severity and Healthcare Resource Utilization for Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: Results from an Integrated Database

National Home Infusion Association (NHIA), 2025

March 29 - April 2, 2025

Annual conference ideal for infusion professionals or those seeking opportunities in the industry to come together and explore the latest trends in offering home-based services. 

Annual Meeting American Academy of Allergy Asthma and Immunology (AAAAI), 2025

February 28 - March 3, 2025

Premier global educational event for allergists and immunologists, with thousands of attendees each year, discussing allergies, asthma, and immune deficiency disorders.

Takhzyro® (lanadelumab-flyo)

  • Real-world Episodes of Long-term Prophylaxis for Hereditary Angioedema: A Descriptive Study Using Data From the Consortium of Independent Immunology Clinics
  • Longitudinal Study of Adult Patients With Hereditary Angioedema Receiving Long-term Prophylaxis for 3 Years or Longer With Lanadelumab: Baseline Findings
  • Understanding the Impact of Long-term Prophylaxis Switches for Patients With Hereditary Angioedema

Western Society of Allergy, Asthma and Immunology (WSAAI), 2025

February 9 - 13, 2025

Annual scientific session uniting allergists, immunologists, nurses, and physician assistants aimed at maintaining the highest standard of practice in allergy care.

Takhzyro® (lanadelumab-flyo)

  • Longitudinal Trend in Attack Outcomes in Patients With Hereditary Angioedema Receiving Long-term Prophylaxis With Lanadelumab: An Observational Study
  • Understanding the Impact of Long-term Prophylaxis Treatment Switches on Hereditary Angioedema Attack Characteristics

Cuvitru®[Immune Globulin Subcutaneous (Human)] 20% Solution

  • Clinical characteristics, treatment patterns, and healthcare resource utilization (HCRU) of patients with primary immunodeficiency diseases receiving immunoglobulin subcutaneous (human), 20% solution (Cuvitru) in a large US payer database